Skip to main content

1 Result(s)

within Chuanjian Tu Remove this filter Cancer Research Remove this filter

and

  1. No Access

    Article

    Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs ER+/PR−/HER2+ breast cancer subtypes

    Breast cancer subtypes based on estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression have significant implications for prognosis. HER2-positive tum...

    Wu Ding, Dengfeng Ye, Haifeng Chen, Yingli Lin, Zhian Li, Chuanjian Tu in Breast Cancer (2024)